Biotech M&A is booming in 2026, driven by patent cliffs and market recovery, signaling the strongest dealmaking since 2019.
Read More

Biotech M&A is booming in 2026, driven by patent cliffs and market recovery, signaling the strongest dealmaking since 2019.
Read More
Novo Nordisk brings Wegovy to the UAE, marking its first international launch and a strategic step in global weight-loss medication…
Read More